3.18. Analysis.
Comparison 3 COMPARISON 3. ARIPIPRAZOLE versus RISPERIDONE, Outcome 18 Adverse effects: 3. Central / peripheral nervous system (short term, up to 12 weeks).
Comparison 3 COMPARISON 3. ARIPIPRAZOLE versus RISPERIDONE, Outcome 18 Adverse effects: 3. Central / peripheral nervous system (short term, up to 12 weeks).